CUMMINGS KEITH LAMONT (Chief Financial Officer) received a stock award from PLIANT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/18/2023ACC: 0001209191-23-042656
Officer· Chief Financial Officer
Since Jun 2020
+38.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
38.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+38.75K
Price / share
—
Trade value
—
% of position
20.9%
7/14/2023
185.02K→223.77K
Total
Net shares
+38.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/14/2023 | A · Award | +38.75K | — | — | 20.9% | 185.02K | 223.77K |
| Total | +38.75K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported